Chesley Taft & Associates LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Chesley Taft & Associates LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,357,509
+1.3%
32,962
+0.4%
0.22%
+7.4%
Q2 2023$3,313,582
+8.0%
32,837
-1.5%
0.20%
+1.0%
Q1 2023$3,067,004
+1.9%
33,337
+0.5%
0.20%
-2.9%
Q4 2022$3,010,725
+15.3%
33,187
-3.4%
0.21%
+7.8%
Q3 2022$2,611,000
-11.0%
34,347
-1.0%
0.19%
-4.0%
Q2 2022$2,933,000
-10.9%
34,697
-2.3%
0.20%
+4.2%
Q1 2022$3,290,000
+0.4%
35,497
-5.2%
0.19%
+12.9%
Q4 2021$3,276,000
+4.2%
37,457
-2.5%
0.17%
-5.0%
Q3 2021$3,143,000
-10.9%
38,432
-0.6%
0.18%
-11.8%
Q2 2021$3,528,000
+5.8%
38,672
+1.2%
0.20%
+2.0%
Q1 2021$3,335,000
-36.4%
38,212
-31.2%
0.20%
-40.6%
Q4 2020$5,243,000
+10.9%
55,520
+2.1%
0.34%
-0.3%
Q3 2020$4,729,000
+1.4%
54,385
+1.8%
0.34%
-5.4%
Q2 2020$4,664,000
+5.0%
53,406
-0.8%
0.36%
-12.1%
Q1 2020$4,440,000
-14.0%
53,849
-1.2%
0.40%
+8.9%
Q4 2019$5,161,000
+7.0%
54,504
-1.8%
0.37%
-0.8%
Q3 2019$4,824,000
-4.9%
55,514
-0.1%
0.37%
-5.6%
Q2 2019$5,072,000
-3.3%
55,548
+1.8%
0.40%
-9.4%
Q1 2019$5,247,000
+11.3%
54,574
-0.6%
0.44%
-4.0%
Q4 2018$4,713,000
-2.5%
54,922
-2.1%
0.46%
+18.2%
Q3 2018$4,836,000
+15.5%
56,125
+1.2%
0.38%
+6.9%
Q2 2018$4,188,000
-16.4%
55,440
-10.5%
0.36%
-19.1%
Q1 2018$5,010,000
-4.4%
61,966
-0.7%
0.44%
+0.2%
Q4 2017$5,239,000
-2.3%
62,402
-0.1%
0.44%
-4.3%
Q3 2017$5,365,000
+5.9%
62,488
+3.0%
0.46%
+1.5%
Q2 2017$5,064,000
+13.9%
60,666
+1.3%
0.46%
+9.1%
Q1 2017$4,447,000
+2.4%
59,872
+0.5%
0.42%
-2.3%
Q4 2016$4,341,000
-8.0%
59,592
-0.3%
0.43%
-9.7%
Q3 2016$4,720,000
-2.5%
59,772
+1.8%
0.48%
-4.4%
Q2 2016$4,842,000
+12.6%
58,687
-1.1%
0.50%
+9.7%
Q1 2016$4,300,000
-17.8%
59,357
-2.4%
0.45%
-17.6%
Q4 2015$5,234,000
-19.0%
60,836
-13.4%
0.55%
-22.0%
Q3 2015$6,460,000
-6.4%
70,275
+0.1%
0.70%
+0.1%
Q2 2015$6,902,000
+0.8%
70,183
+1.1%
0.70%
+0.1%
Q1 2015$6,847,000
+2.7%
69,438
-3.5%
0.70%
+4.3%
Q4 2014$6,668,000
-1.1%
71,962
+0.5%
0.67%
-4.4%
Q3 2014$6,740,000
+3.0%
71,602
-0.9%
0.70%
+4.3%
Q2 2014$6,541,000
+9.6%
72,251
+2.9%
0.68%
+5.6%
Q1 2014$5,968,000
+7.2%
70,191
+1.3%
0.64%
+15.3%
Q4 2013$5,569,000
+5.2%
69,279
+0.4%
0.56%
-3.8%
Q3 2013$5,296,000
+8.3%
69,034
-0.2%
0.58%
+1.8%
Q2 2013$4,891,00069,1740.57%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders